Stockreport

BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT324/DB-1311 in Prostate Cancer [Yahoo! Finance]

BioNTech SE - American Depositary Shares  (BNTX) 
PDF safety profile demonstrated by preliminary Phase 1/2 clinical data from patients with advanced or metastatic solid tumors With the Fast Track designation, the developm [Read more]